NYMX
Nymox Pharmaceutical Corp
NYMX
NYMX
Delisted
NYMX was delisted on the 6th of July, 2023.
32 hedge funds and large institutions have $3.98M invested in Nymox Pharmaceutical Corp in 2013 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
97% less call options, than puts
Call options by funds: $1K | Put options by funds: $32K
Holders
32
Holding in Top 10
–
Calls
$1K
Puts
$32K
Top Buyers
| 1 | +$381K | |
| 2 | +$261K | |
| 3 | +$121K | |
| 4 |
BAS
Brown Advisory Securities
Baltimore,
Maryland
|
+$61K |
| 5 |
EVC
Eidelman Virant Capital
Saint Louis,
Missouri
|
+$53.8K |
Top Sellers
| 1 | -$310K | |
| 2 | -$271K | |
| 3 | -$206K | |
| 4 |
CIBC World Market
Toronto,
Ontario, Canada
|
-$115K |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
-$67.3K |